166 related articles for article (PubMed ID: 17341317)
1. Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials.
Haney S; Hancox RJ
Respir Res; 2007 Mar; 8(1):19. PubMed ID: 17341317
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
3. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
4. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
5. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
6. Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department?
Koutsogiannis Z; Kelly AM
Aust N Z J Med; 2000 Feb; 30(1):38-40. PubMed ID: 10800876
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study.
Aalbers R; Boorsma M; van der Woude HJ; Jonkers RE
Respir Res; 2010 May; 11(1):66. PubMed ID: 20509942
[TBL] [Abstract][Full Text] [Related]
8. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.
Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE
Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125
[TBL] [Abstract][Full Text] [Related]
9. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
Becker AB; Simons FE
J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
[TBL] [Abstract][Full Text] [Related]
10. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP
Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
[TBL] [Abstract][Full Text] [Related]
11. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
12. Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.
Jones SL; Cowan JO; Flannery EM; Hancox RJ; Herbison GP; Taylor DR
Eur Respir J; 2001 Mar; 17(3):368-73. PubMed ID: 11405513
[TBL] [Abstract][Full Text] [Related]
13. Formoterol: a review of its use in chronic obstructive pulmonary disease.
Cheer SM; Scott LJ
Am J Respir Med; 2002; 1(4):285-300. PubMed ID: 14720051
[TBL] [Abstract][Full Text] [Related]
14. Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma.
Garrett JE; Town GI; Rodwell P; Kelly AM
J Allergy Clin Immunol; 1997 Aug; 100(2):165-70. PubMed ID: 9275135
[TBL] [Abstract][Full Text] [Related]
15. Inhaled magnesium sulfate in the treatment of acute asthma.
Knightly R; Milan SJ; Hughes R; Knopp-Sihota JA; Rowe BH; Normansell R; Powell C
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003898. PubMed ID: 29182799
[TBL] [Abstract][Full Text] [Related]
16. Tolerance to beta-agonists during acute bronchoconstriction.
Hancox RJ; Aldridge RE; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Town GI; Taylor DR
Eur Respir J; 1999 Aug; 14(2):283-7. PubMed ID: 10515402
[TBL] [Abstract][Full Text] [Related]
17. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
18. Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma.
Chhabra SK; Pandey KK
J Asthma; 2002 Aug; 39(5):375-81. PubMed ID: 12214891
[TBL] [Abstract][Full Text] [Related]
19. Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.
McCrory DC; Brown CD
Cochrane Database Syst Rev; 2001; 2001(2):CD002984. PubMed ID: 11406052
[TBL] [Abstract][Full Text] [Related]
20. How long should Atrovent be given in acute asthma?
Brophy C; Ahmed B; Bayston S; Arnold A; McGivern D; Greenstone M
Thorax; 1998 May; 53(5):363-7. PubMed ID: 9708227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
